Topouzis, Fotis <br/><br/>
Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.  [electronic resource] 

 -  European journal of ophthalmology  Jan 2021 
 - 103-111 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1724-6016 
<br/><br/><label>Standard No.: </label>10.1177/1120672119878044  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-2 Receptor Agonists--adverse effects<br/>Aged<br/>Aged, 80 and over<br/>Antihypertensive Agents--therapeutic use<br/>Brimonidine Tartrate--adverse effects<br/>Carbonic Anhydrase Inhibitors--adverse effects<br/>Double-Blind Method<br/>Drug Combinations<br/>Female<br/>Glaucoma, Open-Angle--drug therapy<br/>Humans<br/>Intraocular Pressure--drug effects<br/>Latanoprost--therapeutic use<br/>Male<br/>Middle Aged<br/>Ocular Hypertension--drug therapy<br/>Sulfonamides--adverse effects<br/>Thiazines--adverse effects<br/>Tonometry, Ocular<br/>Travoprost--therapeutic use